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Abstract. Delivery and spatial localization of upconversion luminescent microparticles [Y2O3∶Yb, Er] (mean
size ∼1.6 μm) and quantum dots (QDs) (CuInS2∕ZnS nanoparticles coated with polyethylene glycol-based
amphiphilic polymer, mean size ∼20 nm) inside rat skin was studied in vivo using a multimodal optical imaging
approach. The particles were embedded into the skin dermis to the depth from 300 to 500 μm through micro-
channels performed by fractional laser microablation. Low-frequency ultrasound was applied to enhance
penetration of the particles into the skin. Visualization of the particles was revealed using a combination of
luminescent spectroscopy, optical coherence tomography, confocal microscopy, and histochemical analysis.
Optical clearing was used to enhance the image contrast of the luminescent signal from the particles.
It was demonstrated that the penetration depth of particles depends on their size, resulting in a different detection
time interval (days) of the luminescent signal from microparticles and QDs inside the rat skin in vivo. We show
that luminescent signal from the upconversion microparticles and QDs was detected after the particle delivery
into the rat skin in vivo during eighth and fourth days, respectively. We hypothesize that the upconversion micro-
particles have created a long-time depot localized in the laser-created channels, as the QDs spread over
the surrounding tissues. © 2018 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.23.2.026001]
Keywords: upconversion microparticles; quantum dots; skin; fractional laser microablation; optical clearing; luminescence spectros-
copy; optical coherence tomography; confocal microscopy; histochemical analysis.
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1 Introduction
Transcutaneous delivery of micro- and nanocarriers directly to
the targeted sites inside skin allows for excluding the interaction
of drugs with the surrounding tissue during the diffusion and
creating a long-time drug depot inside the skin. Passive diffusion
of the micro- and nanoparticles into deeper layers of skin is
extremely hampered due to protective properties of the skin
barrier.1 Both size and formulation of the particles govern
their penetration into skin.2 For example, less than 0.03% of
the applied ZnO nanoparticles with an average size ≤100 nm
included in a sunscreen formulation penetrate to the human
epidermis.3 As it has been shown by many authors, at skin top-
ical application, the main site of nanoparticle localization in
the skin is hair follicles.2,4 In particular, in Ref. 4, the authors
have studied cutaneous localization of nonbiodegradable poly-
styrene nanoparticles labeled by fluorescein 5-isothiocyanate
using confocal laser scanning microscopy (CLSM). It follows
from the CLSM images that accumulation of 20- and 200-nm
polystyrene particles in follicular openings depends on both
size of the particles and time elapsed, and there are no evidences
of permeation of the nanoparticles in the nonfollicular region.
The authors of Ref. 5 also demonstrate accumulation of ZnO
and TiO2 nanoparticles in hair follicles. To implement targeted
particle delivery deep into the skin, massage,6 low-frequency
sonophoresis,7,8 microporation,9 and fractional laser microabla-
tion (FLMA)10,11 are typically used. FLMA in combination with
ultrasonic treatment is a promising technique for this purpose.12
Creating artificial microchannels in the upper skin layers by
FLMA promotes deeper and more efficient delivery of micro-
and nanoparticles. The sufficiently fast restoration of the skin
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barrier integrity occurring after particle administration reduces
the risk of skin infection.13 Ultrasonic treatment facilitates
administration of micro- and nanoparticles into the skin and
their targeted subsurface localization within the tissue.12
One of the most rapidly developing applications of lumines-
cent particles is their use in molecular and cellular biology,
medical diagnostics and therapy.14–17 For example, in order
to monitor encapsulated drug delivery pathways, luminescent
particles are introduced into microcapsules at the stage of
synthesis.18,19
Currently, quantum dots (QDs) and upconversion particles
(UCPs), along with the traditionally used luminescent labels,
are widely used for biological research.20–25 The use of lumines-
cent spectroscopy allows for detection of optical signal from
micro- and nanoparticles in real time during several days.26
In Ref. 22, the authors have studied the transdermal delivery
capacity of water-soluble CdSeS QDs through mouse skin
and their deposition in the body. Experimental results indicate
that QDs can penetrate into the dermal layer through hair
follicles and then get into blood circulation. QDs were found in
liver and kidney. Dye-containing polymeric 320-nm nano-
particles accumulated in the hair follicles can stay there for
up to 10 days, while a nonparticulate form can be detected
only up to 4 days.6 Subcutaneous injection of ethylenediamine-
tetra (methylenephosphonic acid)-coated (28.9 1.0 nm) and
uncoated (39.2 0.3 nm) NaYF4: Er/Yb nanoparticles in
mice has demonstrated that the particles of both types exhibit
bright green luminescence upon laser excitation of the skin
for up to three days after injection.21
In order to visualize spatial localization of the luminescent
nanoprobe in tissues, deep penetration of excitation radiation
into the tissue is required. In addition, the emitted optical radi-
ation has to be in the so-called “diagnostic” spectral window.27
For this, the upconversion luminescence excited in the near-
infrared (NIR) spectral range can be effectively used. Indeed,
high scattering of the visible and NIR radiation in tissues as
well as optical detection method significantly limits the spatial
resolution and the probing depth.27,28 This problem can be
solved by application of hyperosmotic immersion liquids
known as optical clearing agents (OCAs).20,29
The combined use of several optical imaging techniques,
so called “multimodal imaging,” can provide more advanced
opportunities to visualize spatial distribution of micro- and
nanoparticles within tissues.
In this paper, multimodal optical imaging, i.e., luminescent
spectroscopy, optical coherence tomography and confocal
microscopy, and immersion optical clearing technique are
used for spatial localization and monitoring of upconversion
luminescent microparticles and QDs during days within rat
skin microchannels created by FLMA.
2 Materials and Methods
2.1 Animals
In vivo studies were carried out on six outbred albino rats 1 year
of age and the body mass of ∼400 g. During all experimental
studies, animals were kept in accordance with the European
Convention for the Protection of animals used for experimental
and other scientific purposes.30 Prior to all treatments, the rats
were anesthetized with Zoletil 50 (Virbac, France) in a dose of
0.05 mg∕kg. On the sites under study, hair was thoroughly
removed using a cream for depilation.
2.2 Particles
Commercially available lanthanide-doped UCPs [Y2O3∶Yb, Er]
PTIR660-UF (Phosphor Technology, United Kingdom) with an
average size of ∼1.6 μm and in-house synthesized CuInS2∕ZnS
QDs with an average size ∼20-nm coated with polyethylene
glycol (PEG)-based amphiphilic polymer (see Appendix) were
used in the experiments.
The UCPs have a luminescent band near the 650-nm
wavelength, upon 980-nm laser excitation [Fig. 1(a)]. The
UCPs [Y2O3∶Yb, Er] are a promising new generation of
agents for bioimaging. Upconversion as a phenomenon utilizes
Fig. 1 Luminescent spectra of (a) UCP (excitation wavelength 980 nm) and (b) QDs (excitation wave-
length 405 nm).
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a sequential absorption of multiple photons via long lifetime
(metastable) and real ladder-like energy levels of trivalent
lanthanide ions embedded in an appropriate inorganic host
lattice to produce higher energy anti-Stokes luminescence.31–33
It thereby converts two or more low-energy excitation photons
of NIR light into shorter wavelength emission in NIR and visible
ranges. High photostability, large blue shift of the upconversion
luminescence relative to the wavelength of the exciting radia-
tion, and absorption in the range of maximal transparency
of tissues (600 to 1000 nm) make it possible to track single
particles and perform their long-term detection.34
The synthesized QDs have an irregular shape with the crystal
size less than 10 nm and a hydrodynamic diameter around
20 nm.35 The luminescent peak of QDs is at the 680-nm wave-
length [Fig. 1(b)] with the quantum yield of ∼45% measured at
488-nm excitation with Rhodamine 6G as a reference dye.
Aqueous suspensions of the particles were prepared immedi-
ately before their use. Concentrations of UCPs and QDs were
0.625 μg∕μL and 0.6 × 10−6 mol∕L, respectively. To prevent
aggregation of the particles, UCP and QD suspensions were
sonicated in an ultrasonic bath before their topical application
to the skin surface.
2.3 Experimental Methods
2.3.1 Particle delivery protocol
All six rats were subjected to the procedure of FLMA. For
carrying out the FLMA procedure, a commercially available
Palomar Lux 2940 pulse erbium laser (Palomar Medical
Technologies Inc., USA) operating at the 2940-nm wavelength
was used. Laser pulse energy was 3 J with a duration of 20 ms;
the temporal profile of the pulse was modulated by three
subpulses with duration of each about 5 ms. The laser beam
was split into 64 microbeams using a microlens array. Thus,
64 vertical microchannels were created over the 8 × 8 mm2
skin area.
The animals were divided into two groups. In the first one
(two animals), the efficiency of administration of UCP and
QD suspensions was studied by using ultrasound or massage.
Five sites were marked as shown in Fig. 2(a): the site 0
corresponded to intact skin without any treatment, the sites 1
and 3 were treated by the UCP suspension, and the sites 2
and 4 by the QD suspension. The volume of both suspensions
was equal to 23 μL. The UCPs and the QDs were delivered
into microchannels by using sonophoresis (sites 3 and 4) or
mechanical massage (sites 1 and 2) for 5 min each.
A commercially available device Dynatron 125
(Dynatronics, USA), equipped with a 2.2-cm diameter US
transducer was applied for sonophoresis in the continuous-wave
mode with the frequency of 1 MHz and the power density of
1.5 W∕cm2. Remains of the suspensions were removed from
the skin surface using distilled water.
In the second group (four animals), six sites were marked as
shown in Fig. 2(b): the site 0 corresponded to intact skin without
any treatment, the sites 1 and 4 were treated by UCP suspension,
and the sites 2 and 5 by the QD suspension. The volume of
the applied suspensions was the same as for the first group.
The site 3 remained untreated by any particle suspension. This
site (control) was used for the monitoring of the changes of
skin state after FLMA. The UCPs and the QDs were delivered
into the microchannels by using sonophoresis (the sites 1, 2, 4,
and 5) for 5 min each.
2.3.2 Particle imaging
Imaging of the particles was performed using different optical
modalities, such as optical coherence tomography, luminescent
spectroscopy, and confocal microscopy, as well as conventional
optical microscopy (histological analysis).
The microchannels were visualized just after FLMA and
after filling them by the particle suspensions in the first and
the second groups. The imaging was performed with a commer-
cially available spectral-domain optical coherence tomography
(OCT) system OCP930SR (Thorlabs, USA), operating at
the central wavelength of 930 5 nm with 100 5 nm full-
width-at-half-maximum spectrum and having the following
characteristics: numerical aperture of 0.22, optical power of
2 mW; the scanning length along the skin surface of 6 mm
with the axial and the lateral resolutions on the air of 6.2 and
9.6 μm, respectively.
To study the influence of ultrasound and massage on inten-
sity of luminescent signal from particles inside the skin, we
carried out the spectral measurement immediately after FLMA
and particle delivery in the first group of animals.
For monitoring UCP and QD localization in the rat skin
in vivo (the second group), luminescent spectroscopy was
applied every day during the entire period of in vivo studies
(nine days). Figure 3 schematically shows the experimental
system for detection of UCP and QD luminescent spectra by
Fig. 2 Scheme of the studied sites of rat skin in vivo for (a) the first group and (b) the second group of
experimental animals.
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a spectrometer QE6500 (Ocean Optics, USA). The excitation of
UCPs was performed at 980-nm wavelength and that of QDs
at 405-nm using a semiconductor laser module DMH980-200
(Laser Systems LAS, Russia, 20 mW) and a violet laser pointer
Pen Style (HangZhou NaKu Technology Co. Ltd, China,
300 mW), respectively. The fiber-optic probe was fixed over
the skin surface at the distance of 25 mm. Luminescent spectra
were measured with a 100-ms acquisition time.
The withdrawal of the animals from the experiment and
sampling of tissues for the luminescent and morphological
study was performed on the first day (two rats from the first
and the second groups) and on the last day of the experiment
(two rats from the second group).
Unstained sections were studies with luminescent micros-
copy. Since luminescence of UCPs and QDs is excited by
different wavelengths, we used different equipment for the
observation. Luminescent images of skin histological sections
with QDs were obtained at room temperature (∼20°C) using
a standard confocal luminescent microscope (Leica TCS SP8,
Germany) with 10× and 100× magnification under 405-nm
laser excitation. Images of UCPs were taken with an optical
microscope OGME-PZ (Sapphire, Russia) equipped with a
CCD camera (Videoscan 415/P-USB, Videoscan, Russia) under
980-nm laser excitation.
Then the sections were stained with hematoxylin–eosin
according to the standard procedure.36 Morphometric studies
of histological preparations were done using a digital image
analysis system μVizo-103 medical microvisor (LOMO,
Russia).
2.3.3 Optical clearing agent
To enhance the luminescent signal from the particles inside skin
dermis, the skin sites 1, 2, and 3 were exposed during 20 min
to OCA Omnipaque™ (GE Healthcare, Ireland) before each
spectroscopic measurement.
Omnipaque™ (Iohexol; GE Healthcare, Ireland) was used as
an OCA to decrease skin scattering. Omnipaque™ is a nonionic,
water-soluble x-ray contrast agent with iodine concentration of
300 mg∕mL commonly used for in vivo angiography and
imaging of internal organs (arteriography, phlebography, etc.).
Iohexol has a low osmolarity comparable with blood plasma
and cerebral spinal fluid. It is approved by the U.S. Food
and Drug Administration (FDA) for in vivo topical use.
Omnipaque™ (300) has molecular weight of 821, neutral
pH (6.8 to 7.6), refractive index 1.439 at the wavelength
589 nm, and low toxicity.
3 Results and Discussion
3.1 Optical Coherence Tomography Imaging
Figure 4 shows the series of OCT images of skin sites from the
first group of rats immediately after FLMA alone (a), FLMA
followed by QD delivery with massage (b), FLMA followed
by UCP delivery with massage (c), FLMA followed by QD
delivery with sonophoresis (d), and FLMA followed by UCP
delivery with sonophoresis (e). In the images, two layers—
epidermis (E) and dermis (D)—are clearly distinguishable.
Microchannels (MC) look like cones. Figure 4(a) allows for
evaluation of the separation between the centers of the laser-
perforated channels as ∼1 mm with the diameter of their
openings at skin surface as 150 to 250 μm and the depth as
450 to 500 μm.
As follows from OCT images (c) and (e), after both massage
and sonophoresis, the largest part of the microchannel is filled
up by the UCP suspension. It is well seen that QDs cannot be
visualized with high-contrast on the background of the skin scat-
tering [see images (b) and (d)]. UCPs provide high contrast of
OCT visualization of the microchannels because of their much
Fig. 4 The OCT images of FLMA-treated skin in vivo: (a) immediately
after FLMA, (b) after QD delivery using a massage; (c) after UCP
delivery using a massage; (d) after QD delivery using a sonophoresis,
and (e) after UCP delivery using a sonophoresis. E, epidermis;
D, dermis; and MC, microchannel.
Fig. 3 Scheme of the experimental setup used for spatial localiza-
tion of upconversion luminescent particles and QDs inside rat skin
in vivo.
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larger size than QDs (1.6 μm versus 20 nm). Comparison of data
presented in Figs. 4(c) and 4(e) shows that in contrast to the
massage, the ultrasound treatment allows for deeper filling of
the ablated channels in the skin. It is in a good agreement
with the results of Ref. 12, where the increase of skin permeabil-
ity for both in vitro and in vivo studies using ultrasound irradi-
ation was shown.
3.2 Luminescent Analysis
The spatial localization of the particles in the microchannels
immediately after FLMA and the particles delivery can
be observed on luminescent images presented in Fig. 5.
Luminescence of UCPs was detected by optical microscope
under 980-nm laser excitation [see Figs. 5(a) and 5(b)] and
luminescent of QDs was detected by confocal microscope
under 405-nm laser excitation [see Figs. 5(c) and 5(d)].
It is well seen that near the skin surface, the particles were
localized along the channel walls; the main volume of the sus-
pensions, apparently, was removed from the channels during the
washing-off. However, as we can see in Fig. 4, the suspension
remained at the depth of 400 to 500 μm. After healing of the
tissue around the channels and as a result of their closing,
the particles are accumulated within a localized space in tissue.
QDs and UCPs were not detected in the histological sections
with a confocal luminescent microscope after nine days of
particle delivery.
Figure 6 shows the luminescent spectra of the UCPs
[see Fig. 6(a)] and QDs delivered into skin by massage
and sonophoresis [see Fig. 6(b)]. It can be seen that sonopho-
resis results in the increased luminescent signal from the
particles in comparison with the massage, apparently, due to
the increase of quantity of the particles penetrated into the
channels.
Measured kinetics of luminescent intensity (Figs. 7 and 8)
and histological analysis (Figs. 9 and 10) confirm that the
depot of the particles can be created inside the microchannels.
Figure 7 shows the luminescent intensity produced by UCPs
(a) and QDs (b) embedded into the rat skin in vivo.
Under excitation by 980-nm laser, skin autofluorescence in
the red spectral region is negligible. By contrast, 405-nm radi-
ation excites fluorescence from endogenous skin fluorophores:
three bands of porphyrins in the 630 to 710-nm region and
NADH near 480 nm.37
The luminescent peak of QDs shifted in the skin from 680 to
670 nm overlaps with the fluorescent bands of porphyrins
[see Fig. 7(b)]. The QD and UCP luminescence was observed
for four days [see Fig. 7(b) (3, 4)] and eight days [see Fig. 7(a)
(3, 4)], respectively, with a gradual decrease in the intensity
with time.
Fig. 5 Luminescent images of histological section of the perforated skin obtained using: (a, b) an optical
microscope equipped with CCD camera under 980-nm laser excitation of the UCPs and (c, d) a confocal
microscope under 405-nm laser excitation of the QDs. The fluorescing UCPs are marked with the red
circle. The images were obtained from the depth of (c) 0 μm and (d) 40 μm immediately after FLMA and
particle delivery.
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Healing and regeneration of skin epidermis (about 4 to
5 days) can prevent penetration of 405-nm light to the QD
depot in the skin. At the same time, 980-nm light penetrates
significantly deeper and can excite luminescence of UCPs for
more prolonged time during skin healing and regeneration and
afterward.
The decrease of luminescent signal can also be connected
with the diffusion of the particles from the observation zone
to surrounding tissues. In Ref. 38, it was shown that contrast
of OCT-images of human skin with embedded particles also
decreased during a few days after their delivery. After the
full regeneration of the skin integrity, quantity of the particles
was so little that they did not register in the OCT images.
Difference between time interval (days) during which lumines-
cence from UCPs and QDs is detectable can be related to
particle size and their diffusion from the initial delivery volume:
larger UCPs remained localized inside the skin channels for a
long time, whereas much smaller QDs diffuse from the channels
and distributed in the surrounding tissues.
It is well seen that the maximal luminescent signal is
observed after the skin optical clearing. Figure 8 shows kinetics
of the maximal intensity of the luminescent bands of the UCPs
Fig. 7 Luminescent spectra of the (a) UCPs (excitation wavelength 980 nm) and (b) QD (excitation
wavelength 405 nm) embedded into rat skin by sonophoresis: with topically applied Omnipaque™
immediately after FLMA and particle delivery (1); without Omnipaque™ immediately after FLMA
and particle delivery (2); with Omnipaque™ after eight days of particle delivery (3); and without
Omnipaque™ after eight days of particle delivery (4). Asterisk represents luminescent bands of endog-
enous porphyrins.
Fig. 6 Luminescent spectra of the (a) UCPs (excitation wavelength 980 nm) and (b) QDs (excitation
wavelength 405 nm) delivered into skin by massage and by sonophoresis. Asterisk represents lumines-
cent bands of endogenous porphyrins.
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(λmax ¼ 658 nm) (a) and QDs (λmax ¼ 680 nm) (b) embedded
into the rat skin by sonophoresis and with and without optical
clearing by topical application of Omnipaque™.
Figures 7 and 8 show that the topical application of the
immersion agent Omnipaque™ allows for enhancement of
the luminescent signal from the particles located inside skin
dermis due to reduction of light scattering of tissue layers,
where excitation and fluorescent signals propagate. This is a
so-called optical clearing technique application that increases
probing depth and contrast of optical imaging methods.29
It was demonstrated, in particular, for fluorescent spectroscopy
and microscopy.20,27,29 Omnipaque™ has refractive index
(1.439) close to refractive index of main skin scatterers—colla-
gen fibers (1.43).27 Thus, a partial replacement of the interstitial
fluid by Omnipaque™ causes the matching of the refractive
indices of the tissue components, its better homogeneity and
reduction of scattering.
In Fig. 8(a), we can see that skin treatment by Omnipaque™
does not affect the intensity of the luminescent signal after four
days post-FLMA and particle delivery. We suppose that after
full regeneration of skin barrier function, Omnipaque™ does
not penetrate effectively into skin dermis, and therefore, the
20-min agent application is not enough for signal enhancement.
3.3 Histological Analysis
Microphotographs of histological sections of the studied skin
areas from the first group measured immediately after UCPs
delivery are shown in Fig. 9. The control sample [intact skin
without any treatment; see Fig. 9(a)] represents skin with normal
multilayer epithelium (epidermis). The skin appendages are vis-
ible in the dermis. QDs could not be detected in the histological
sections with conventional optical microscopy due to their small
size (20 nm).
For the samples taken from the FLMA-zone [ablation only;
see Fig. 9(b)], crater-like defects crossing epidermis and dermis,
regularly occurring on average every 600 μm with the develop-
ment of coagulation necrosis in tissue around them, are
observed. In Fig. 9(b), one of the craters covers an area of
width × depth equal to 153 × 170 μm2 as the maximal depth
of necrosis edge is 363 μm. Coagulation necrosis of the thick-
ness about 10 μm is formed around the perforated channel.
In addition, full-blooded vessels around the zone of influence
are observed.
Figure 9(c) shows UCPs on crater walls delivered by
massage; this crater is an internal part of the microchannel.
Outside, the channel is surrounded by a necrotic zone with
a radius approximately equal to the crater depth. The size of
the crater is 155 × 58 μm2.
It is important to note that sonophoresis increases the channel
size. The form of the channel changes from conical to spherical.
We anticipate that the necrotic tissue is detached and pushed out
from the channel by sonophoresis. This hypothesis is confirmed
by a thinner zone of coagulation necrosis observed in Fig. 9(d)
than in Fig. 9(c).
Figure 10 presents a fragment of skin with a microchannel
filled by UCPs of the rat from the second group. A depth of
localization is 323 μm. The size of the defect is 21 × 63 μm2.
Analysis of this histological section confirms our hypothesis
that particles with the microscale dimension localized inside
the channels remain there after the channel healing and do
not penetrate in surrounding tissue. Thus, a depot of particles
can be created for prolonged drug release.
QDs, on the contrary, can diffuse through the surrounding
tissue and leave the channel zone. Therefore, we cannot
see accumulation of the particles in the histological sections
and luminescent signal to the ninth day post-treatment.
It was shown earlier that the use of FLMA allowed for
delivery of microparticles into dermis and creation of a particle
depot.11,38,39 For example, biocompatible CaCO3 microcon-
tainers (4.0 0.8 μm) containing Fe3O4 nanoparticles were
delivered to the depth about 300 μm in dermis.11 On the seventh
Fig. 8 The time dependence of the luminescent maximum of the (a) UCPs (λmax ¼ 658 nm) and (b) QDs
(λmax ¼ 680 nm) embedded into the rat skin by sonophoresis and with (black squares) and without
(red circles) optical clearing by topical application of Omnipaque™.
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day, the dissolving of the microcontainers and release of the
content into dermis was observed. In Refs. 38 and 39, it was
shown that particles with diameter about 100 nm and more
can remain in skin in vivo during 30 days.
4 Conclusions
It is shown that UCPs are visualized in skin more efficiently in
comparison with QDs. The UCPs have a stable narrow-band
emission at excitation in the NIR spectral range. Under excita-
tion by 980-nm laser, the skin autofluorescence in the spectral
region of the microparticle luminescence is absent. The lumines-
cent images of the UCPs distribution indicate the advantage
of the particle delivery into the skin by FLMA with sonopho-
resis. The UCPs are observed in the channels by optical coher-
ence tomography, conventional microscopy, and luminescent
imaging during eight days after the skin treatment. The QDs
luminescence is detected for four days with a gradual decrease
of the intensity. It is shown that the use of the immersion agent
Omnipaque™ results in the enhancement of the luminescent
signal from the particles inside skin dermis. In the process of
the channel healing, QDs were displaced from the channels
to the surface of the skin. This fact explains the absence of
the QD luminescence signal on the fifth day of the experiment.
The UCPs were located deeper in the tissue and remained there
after the healing of the channels. This explains the presence of
the luminescent signal of the UCPs for eight days. The differ-
ence in the depth of the particles localization can be explained
by the fact that ultrasound more effectively influences heavier
and larger UCPs than QDs.
Thus, the multimodal imaging approach provides capabilities
for a more advanced investigation of spatial localization of
Fig. 9 Histological sections of the skin: (a) intact skin, (b) skin after laser ablation without embedded
particles, (c) with the UCPs delivered by massage, and (d) with the UCPs delivered by sonophoresis
(the mean size of the skin damaged area ½260 70 × ½110 30 μm2). The samples were stained
with hematoxylin and eosin. The contoured zones indicate coagulation necrosis (b, c, d).
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UCPs and QDs within the skin, which is of interest for different
biomedical applications.
Appendix: CuInS2/ZnS Core/Shell Synthesis
A Zn precursor was prepared by mixing 1.6-g zinc stearate
ZnðStÞ2 (2.53 mmol), 4.3-mL oleic acid, 14-mL octadecene
in a flask and flushing the mixture for 30 min with nitrogen,
followed by heating up to 190°C until a colorless solution
was obtained.35 Then the flask was cooled down to 90°C,
0.84 mL dodecanethiol was added and the mixture was left
under nitrogen at 75°C for further use. For the core/shell syn-
thesis, the flask with CuInS2 cores grown at 220°C was cooled
down to 80°C. At this temperature, 2.7 mL of the Zn precursor
(Zn∶In ¼ 1∶1) was added and the flask was immediately heated
up to 215°C and was kept at this temperature for 30 min.
Afterward, the flask was cooled down again to 80°C, 2.7 mL
of the Zn precursor (2.7 ml) was added followed by heating
up the flask again up to 215°C. The same procedure was
repeated five times. Finally, the solution was cooled down,
diluted with chloroform [VðCHCl3Þ: VðsolutionÞ ¼ 1∶5] and
centrifuged at 3000g for 10 min. The formed precipitate was
discarded, and ethanol was added to the supernatant until
opalescence.35 The mixture was centrifuged at 3000g for
10 min and the supernatant was decanted. The precipitate was
dispersed in toluene. This precipitation/dissolution procedure
was repeated three times and in such a way obtained QDs
were stored in toluene at 4°C.35
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